The Patent Finder

Terms ending in 2029

Respivert Limited

Every in-force patent on Respivert Limited's record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,293,748P38 Map Kinase Inhibitors
In force
 · Medium confidence
Respivert Ltd.In forceMedium confidence
US 8,293,771P38 Map Kinase Inhibitors
In force
 · Medium confidence
Respivert Ltd.In forceMedium confidence
US 8,975,285P38 Map Kinase Inhibitors
In force
 · Medium confidence
Respivert Ltd.In forceMedium confidence
US 9,024,041P38 Map Kinase Inhibitors
In force
 · Medium confidence
Respivert Ltd.In forceMedium confidence
US 9,260,410P38 Map Kinase Inhibitors
In force
 · Medium confidence
Respivert Ltd.In forceMedium confidence
US 9,771,354Pyrazole P38 Map Kinase Inhibitors
In force
 · Medium confidence
Respivert LimitedIn forceMedium confidence
US 8,299,073P38 Map Kinase Inhibitors
In force
 · Medium confidence
Respivert Ltd.In forceMedium confidence
US 9,242,960P38MAP Kinase Inhibitors
In force
 · Medium confidence
Respivert Ltd.In forceMedium confidence
8 of 8 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited